DEC 23, 2018 10:51 PM PST

Super-Drug for Pediatric Leukemia?

WRITTEN BY: Nouran Amin

In a final study published in Genes & Development, researchers at Northwestern University School of Medicine concluded their discoveries on two successful therapeutics that were seen to slow the progression of pediatric leukemia in model mice through the targeting of a key protein called MLL. "This opens up a new therapeutic approach not only for leukemia, which is so important for the many children who are diagnosed with this terrible cancer, but also for other types of cancers that plague the population," says first author and postdoctoral research fellow, Zibo Zhao.

Learn more about pediatric leukemia:

The mortality rate of childhood leukemia, a cancer affecting the blood and bone marrow, is very high with just a 30 percent survival rate. The study focused primarily on two of the most commonly found leukemia’s in children: acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL).

Credit: The Dana Farber Cancer Institute

"These white blood cells infiltrate many of the tissues and organs of the affected individuals and is a major cause of death in leukemia patients," says senior author of the study, Ali Shilatifard. "This is a monster cancer that we've been dealing with for many years in children."

The study identified the MLL stabilization process that therapeutically treats the cancer. Researchers are now hoping to combine these successful therapeutics for the ultimate ‘super-drug’ in targeting MLL effectively and decreasing the mortality rate among children diagnosed with pediatric leukemia. "I've been working on this translocation for more than two decades, and we're finally at the point where in five to 10 years, we can get a drug in kids that can be effective," Shilatifard said. "If we can bring that survival rate up to 85 percent, that's a major accomplishment."

Source: Genes & Development, Northwestern University

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 20, 2020
Drug Discovery & Development
Cholesterol-Lowering Drugs Reduce The Severity of COVID-19
SEP 20, 2020
Cholesterol-Lowering Drugs Reduce The Severity of COVID-19
Almost a year into the beginnings of the COVID-19 pandemic and we still do not have a Food and Drug Administration (FDA) ...
SEP 29, 2020
Cardiology
Improving Acute Myocardial Ischemia Treatment with Nitro Fatty Acids
SEP 29, 2020
Improving Acute Myocardial Ischemia Treatment with Nitro Fatty Acids
Acute myocardial ischemia occurs when blood flow is restricted in the heart. This usually leads to cardiovascular issues ...
NOV 01, 2020
Cannabis Sciences
Can Cannabis Treat ALS?
NOV 01, 2020
Can Cannabis Treat ALS?
Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative illness that damages motor neurons and leads to progressive m ...
NOV 15, 2020
Drug Discovery & Development
Antidepressant May Prevent Worsening of COVID-19 Infections
NOV 15, 2020
Antidepressant May Prevent Worsening of COVID-19 Infections
  Researchers from the Washington University School of Medicine in St. Louis have found that fluvoxamine, a common ...
NOV 20, 2020
Drug Discovery & Development
Cat Parasite Gives Clues on New Drug Targets for Schizophrenia
NOV 20, 2020
Cat Parasite Gives Clues on New Drug Targets for Schizophrenia
Researchers from the UK and France have discussed a mechanism of action behind the infamous Toxoplasma gondii  ...
NOV 15, 2020
Drug Discovery & Development
Drug Stimulates Female Fertility
NOV 15, 2020
Drug Stimulates Female Fertility
A recent drug, MVT-602, was found to stimulate fertility by acting on the natural 'kisspeptin' hormone system in ...
Loading Comments...